- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Mettler-Toledo International Inc(MTD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MTD
11/19/2026: MTD (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Mettler-Toledo International Inc is a prominent global supplier of precision instruments and services for laboratory, industrial, and food retailing applications. The company has a leading position in weighing and analytical measurement, supported by high operating margins and a robust direct service network. Its primary growth opportunity lies in secular life-science research trends, laboratory automation, and strict food safety regulations. However, investors must monitor risks related to macroeconomic cyclicality, industrial spending slowdowns, and a premium valuation multiple. The stock is best suited for growth-oriented investors looking for high-quality industrial franchise exposure while keeping an eye on capital expenditure cycles.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit while signal remains positive | Enjoys steady secular drivers from life sciences research and automated laboratory infrastructure. |
| Momentum investor | Mixed fit | Performance depends on periodic industrial and tech capital expenditure cycles rather than explosive short-term momentum. |
| Value investor | Weak fit | Trades at a premium valuation multiple due to its consistent quality and high return on capital. |
| Dividend investor | Weak fit | The company relies primarily on share repurchases rather than cash dividends to return capital. |
| Low-risk investor | Medium | Offers solid business stability and strong market positioning, though equity market volatility still applies. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | Stock price can experience fluctuations driven by broader market sentiment and quarterly industrial data. |
| Valuation risk | Medium / high | High price-to-earnings multiples leave less margin for error if earnings growth slows down. |
| Competition risk (analytical instruments and life science tools) | Medium | Faces continuous competition from well-capitalized life science instrumentation giants. |
| Business quality | Strong | Possesses a high-quality franchise with strong margins and deeply embedded customer relationships. |
| Dividend income | Low / none | Investors looking for regular dividend income will not find meaningful payouts here. |
| Execution risk | Medium | Maintaining operational efficiency across global manufacturing and supply chains is critical for margin protection. |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 33.94B USD | Price to earnings Ratio 37.04 | 1Y Target Price 1737.5 |
Price to earnings Ratio 37.04 | 1Y Target Price 1737.5 | ||
Volume (30-day avg) 188.5K shares | Beta 1.17 | 52 Weeks Range 1023.05 - 1806.58 | Updated Date 11/19/2026 |
52 Weeks Range 1023.05 - 1806.58 | Updated Date 11/19/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 46.07 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 61.0%
- Active BUY / eligible
- 64 / 105
- 30-Day BUY Count Change
- +16
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Diagnostics & Research
- BUY participation
- 42.9%
- Active BUY / eligible
- 6 / 14
- 30-Day BUY Count Change
- -3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 0.81% | Avg. Invested days 50 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Laboratory Instruments | Sale of precision balances, pipettes, and analytical instruments to academic, pharma, and industrial labs. | This is a stable, high-margin revenue driver tied to global scientific research budgets. |
| Industrial & Product Inspection | Heavy-duty weighing scales, checkweighers, and metal detection systems for factories and food packaging. | Provides cyclical exposure to manufacturing automation and stringent food safety compliance. |
| Geographic Exposure (Global) | Revenues distributed across the Americas, Europe, and Asia/Rest of World. | Diversified international footprint helps cushion regional economic downturns. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When After Market | Estimate 12.11 | Actual 12.57 |
Profitability
Profit Margin 22.25% | Operating Margin (TTM) 27.82% |
Management Effectiveness
Return on Assets (TTM) 20.23% | Return on Equity (TTM) 29.51% |
Valuation
Trailing PE 37.04 | Forward PE 33.22 | Enterprise Value 36.53B | Price to Sales(TTM) 8.08 |
Enterprise Value 36.53B | Price to Sales(TTM) 8.08 | ||
Enterprise Value to Revenue 8.7 | Enterprise Value to EBITDA 27.53 | Shares Outstanding 19.89M | Shares Floating 19.78M |
Shares Outstanding 19.89M | Shares Floating 19.78M | ||
Percent Insiders 0.45 | Percent Institutions 105.6 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

